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Background: Chronic low grade inflammation during obesity is associated with impairments in the insulin signaling
cascade.
Results:Oleate and palmitate elicit opposite effects in insulin signaling in hepatocytes through macrophage stimulation.
Conclusion: An endocrine/paracrine cross-talk between macrophages/Kupffer cells and hepatocytes modulates insulin
signaling.
Significance: Switching macrophage/Kupffer cell polarization will be of benefit against insulin resistance in the liver.
Chronic lowgrade inflammation in adipose tissue during obe-
sity is associated with an impairment of the insulin signaling
cascade. In this study, we have evaluated the impact of palmitate
or oleate overload of macrophage/Kupffer cells in triggering
stress-mediated signaling pathways, in lipoapoptosis, and in the
cross-talk with insulin signaling in hepatocytes. RAW 264.7
macrophages or Kupffer cells were stimulated with oleate or
palmitate, and levels of M1/M2 polarization markers and the
lipidomic profile of eicosanoids were analyzed. Whereas proin-
flammatory cytokines and total eicosanoids were elevated in
macrophages/Kupffer cells stimulated with palmitate, en-
hanced arginase 1 and lower leukotriene B4 (LTB4) levels were
detected in macrophages stimulated with oleate. When hepato-
cytes were pretreated with conditioned medium (CM) from
RAW 264.7 or Kupffer cells loaded with palmitate (CM-P),
phosphorylation of stress kinases and endoplasmic reticulum
stress signaling was increased, insulin signaling was impaired,
and lipoapoptosis was detected. Conversely, enhanced insulin
receptor-mediated signaling and reduced levels of the phospha-
tases protein tyrosine phosphatase 1B (PTP1B) and phospha-
tase and tensin homolog (PTEN) were found in hepatocytes
treated with CM from macrophages stimulated with oleate
(CM-O). SupplementationofCM-OwithLTB4 suppressed insu-
lin sensitization and increased PTP1B and PTEN. Furthermore,
LTB4 decreased insulin receptor tyrosine phosphorylation in
hepatocytes, activated the NFB pathway, and up-regulated
PTP1B and PTEN, these effects being mediated by LTB4 recep-
tor BTL1. In conclusion, oleate and palmitate elicit an opposite
cross-talk betweenmacrophages/Kupffer cells and hepatocytes.
Whereas CM-P interferes at the early steps of insulin signaling,
CM-O increases insulin sensitization, possibly by reducing
LTB4.
Evidence from clinical and epidemiological studies has
clearly established that obesity is the most common cause of
insulin resistance, type 2 diabetes mellitus and non-alcoholic
fatty liver disease. In fact, insulin resistance in peripheral tis-
sues, such as liver and skeletal muscle, is an early metabolic
abnormality in the development of type 2 diabetes mellitus (1).
Although the precise molecular mechanisms underlying insu-
lin resistance associated with obesity have not been completely
elucidated, one major contributor is the chronic low grade sys-
temic inflammation state that interferes with the early steps of
the insulin signaling cascade, possibly through the effects of
free fatty acids (FFAs)3 and cytokines secreted by the overgrow-
ing white adipose tissue (2–4).
Proinflammatory cytokines impair insulin action by activat-
ing stress kinases such as c-JunNH2-terminal kinase (JNK), IB
kinase (IKK), and also protein kinase C (PKC)-mediated path-
ways (5, 6). In addition, cytokines down-regulate early key
mediators of the insulin signaling cascade, such as the insulin
receptor (IR) or insulin receptor substrate 1 (IRS1) (7, 8), as well
as increase the expression of negative modulators of this path-
way, such as the protein-tyrosine phosphatase 1B (PTP1B) (9,
10). On the other hand, circulating FFAs, which are usually
increased in insulin-resistant states (11–13), also activate these
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proinflammatory pathways, boosting the defects in peripheral
insulin actions (14–16).
In addition to the inflammatory effects, the activation of
endoplasmic reticulum (ER) stress-mediated signaling path-
ways by FFAs has been linked to obesity-associated immuno-
metabolic dysregulation and insulin resistance (17, 18). ER
stress is sensed by three main proteins, X-BP1 (X-box-binding
protein 1), PERK (PRKR-like endoplasmic reticulum kinase),
and ATF6 (activating transcription factor-6), which cooperate
tomitigate ER stress by reducing protein translation, stabilizing
proteins by chaperones, and activating ER-associated protein
degradation (19). Chemical chaperones (tauroursodeoxycholic
acid and 4-phenylbutryate) that alleviate ER stress through pro-
tein stabilization, improve systemic glucose homeostasis,
increase glucose uptake in adipose and skeletal muscle, and
reduce hepatic glucose production (20). Moreover, a study in
obese subjects has revealed that treatment with tauroursode-
oxycholic acid increases insulin sensitivity in liver and skeletal
muscle by30% compared with the placebo therapy (21).
FFA-derived metabolites are relevant factors in the patho-
genesis of the metabolic syndrome (22). Eicosanoids (prosta-
glandins (PGs), tromboxanes, leukotrienes (LTs), and cyto-
chrome P450metabolites) are bioactive lipids synthesized from
polyunsaturated FFAs, such as proinflammatory -6 arachi-
donic acid or anti-inflammatory -3 eicosapentaenoic acid,
and docosahexaenoic acid through the cyclooxygenases,
lipoxygenases, and cytochrome P450 pathways. The functional
role of eicosanoids in obesity and insulin resistance has recently
been studied in humans and animal models. For instance, an
accumulation of polyunsaturated FFAs, leukotriene B4 (LTB4),
and 6-keto-prostaglandin-F1 was observed in plasma from
patients withmetabolic syndrome (23).Moreover, the develop-
ment of insulin resistance in patients affected bymetabolic syn-
drome leads to increased synthesis of thromboxaneA2. Regard-
ing studies in cellular and animal models, it was shown that
PGE2 aggravates insulin resistance induced by interleukin 6
(IL6) in hepatocytes (24), whereas BLT1 (LTB4 receptor 1)-de-
ficient mice are resistant to high fat diet-induced obesity and
insulin resistance (25).
Several studies have reported that besides adipocytes,
adipose tissue resident macrophages, which migrate and accu-
mulate in white adipose tissue, have a relevant role in obesity-
induced chronic inflammation (26–28) through their po-
larization toward the M1-like state (29). Although the
importance of macrophages in themolecular mechanisms trig-
gering insulin resistance in skeletal muscle and adipose tissue
has been explored (29–31), it remains unclear whether the
inflammatory milieu impacts insulin signaling in hepatocytes.
On that basis, in this study, we have investigated for the first
time the effect of macrophages activated by two distinct FFAs,
palmitate (saturated) and oleate (unsaturated), on stress-medi-
ated pathways, lipoapoptosis, and the insulin signaling cascade
in hepatocytes.
EXPERIMENTAL PROCEDURES
Reagents—Fetal bovine serum (FBS) (catalog no. 10270) and
culture medium DMEM (catalog no. 41966–029) were ob-
tained from Invitrogen. TRIzol reagent (catalog no. T9424),
sodium palmitate (catalog no. P9767), sodium oleate (catalog
no. O7501), bovine serum albumin (BSA) (catalog no. A6003),
fatty acid-free BSA endotoxin-free (catalog no. A8806), and
insulin (catalog no. I0516) were from Sigma-Aldrich. Bradford
reagent, acrylamide, immunoblotting PVDF membrane, and
Immobilon Western chemiluminescent HRP substrate were
purchased from Bio-Rad.
Free Fatty Acid Preparation—2.5 mM FFA stock solutions
were prepared by a modification of the Spector method (32).
Briefly, cold sodium palmitate or sodium oleate was dissolved
in 0.1 M NaOH by heating at 70 °C while 0.5 mM BSA solution
was prepared by dissolving fatty acid-free BSA in NaCl 0.9% by
heating at 50 °C (at maximum). Once BSA and FFA solutions
were completely dissolved, palmitate and oleate solutions were
diluted 10 times in the BSA solution and mixed by pipetting to
achieve a final molar ratio of 5:1. Control BSA was prepared by
adding the same amount of 0.1 M NaOH into 0.5 mM BSA solu-
tion. All preparations were filtered, aliquoted, and stored at
20 °C.
Culture of RAW 264.7MurineMacrophages and Immortalized
Hepatocytes—The murine RAW 264.7 macrophage cell line,
kindly provided by Dr. Tarín (CNIC, Madrid, Spain), was cul-
tured in RPMI supplemented with 10% heat-inactivated FBS,
100 units/ml penicillin, 100g/ml streptomycin, and 2mM glu-
tamine. The generation and characterization of immortalized
mouse hepatocyte cell line have been described previously (33).
Cells were grown inDMEMplus 10% heat-inactivated FBS, 100
units/ml penicillin, 100 g/ml streptomycin, and 2 mM gluta-
mine. Confluent macrophages were treated with BSA or FFA
solutions (750Mconjugated oleate/BSAor 750Mconjugated
palmitate/BSA) for 24 h to obtain the corresponding condi-
tioned medium (CM) (31). CM were centrifuged to remove
dead cells and directly added (without dilution) to hepatocytes
for several time periods. In all experiments, comparablemRNA
levels of pro- and anti-inflammatory markers were observed in
RAW 264.7 macrophages.
Isolation and Culture of Kupffer Cells—For Kupffer cell iso-
lation, the supernatant from the first centrifugation of the hepa-
tocyte isolation protocol was collected and centrifuged twice at
50 g for 5 min to discard the pellet with the remaining hepa-
tocytes. The latest supernatant was centrifuged at 500 g for 5
min at 4 °C, and the pellet containing the Kupffer cells was
resuspended in attachment medium. Cells were mixed by
inversion with 50% Percoll and centrifuged at 1.059 g for 30
min without acceleration or brake at room temperature.
Finally, the Kupffer cell pellet was washed with 1 PBS and
centrifuged twice at 500 g for 10 min at 4 °C to wash out the
residual Percoll solution, and cells were resuspended in RPMI
supplemented with 10% heat-inactivated FBS, 100 units/ml
penicillin, 100 g/ml streptomycin, and 2 mM glutamine. Cells
were then plated on 12-well plates and maintained for 24 h
before treatments. Conditioned medium was prepared as
described in RAW 264.7 cells.
Primary Hepatocyte Cell Culture—Human hepatocytes were
isolated by the two-step collagenase procedure from non-tu-
mor areas of liver biopsies from patients submitted to a surgical
resection for liver tumors after obtaining patients’ written con-
sent (34). Primary mouse hepatocytes were isolated from non-
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fasting male C57BL/6 mice (10–12 weeks old) by perfusion
with collagenase as described (35). Cellswere seeded on a 6-well
plate (Corning, Inc.) and cultured in medium containing Dul-
becco’smodified Eagle’smedium andHam’s F-12medium (1:1)
with 10% FBS, supplemented with 2 mM glutamine, 100
units/ml penicillin, 100 g/ml streptomycin, and 1 mM sodium
pyruvate (attachment medium) and maintained for 24 h before
treatments. The generation and characterization of the immor-
talized mouse hepatocyte cell line have been described previ-
ously (33).
Transfection with siRNA—siRNA oligonucleotides were syn-
thesized by Ambion (Life Technologies) for gene silencing of
mouse BLT1 and arginase 1. Immortalized mouse hepatocytes
or RAW 264.7 macrophages were seeded in 6-cm dishes and
incubated at 37 °Cwith 5%CO2 overnight.When 40–50% con-
fluence was reached, cells were transfected with BLT1 or argi-
nase 1 siRNA at different concentrations (5–25 nM) or with a
scrambled siRNA, used as a control. After 36 h, cells were used
for experiments.
Analysis of FFA-derived Metabolites—0.01% (w/v) of butyl-
ated hydroxytoluene in methanol was added to supernatants to
prevent metabolite degradation. CM collected from macro-
phages treated with BSA or FFAs solutions were melted slowly,
and 400 pmol of deuterated PGE2 and LTB4 were added as
internal standards before solid phase extraction. Lipid metabo-
lites were extracted using Bond Elut Plexa solid phase extrac-
tion columns (Agilent Technologies, Santa Clara, CA) as indi-
cated by the manufacturer. Columns were homogenized with 3
ml of methanol followed by 3 ml of water. Supernatants were
acidified with 0.5% acetic acid, and 10% methanol was also
added before sample loading. Sampleswerewashedwith 3ml of
10% methanol, and finally, lipid products were eluted with 2
1.5 ml of 100% methanol. Lipid metabolites were concentrated
under vacuum and redissolved in 100 l of solvent A (water/
acetonitrile/acetic acid, 70:30:0.02 (v/v/v)) for their analysis by
HPLC/MS/MS. The chromatographic protocol was adapted
from Dumlao et al. (36). Quantification was carried out by the
integration of chromatographic peaks of the previously identi-
fied species compared with an external calibration curve made
with analytical standards. The software Analyst 1.5.2 was
employed in this process.
Preparation of Protein Extracts andWestern Blot—To obtain
total cell lysates, attached cells were scraped off and incubated
for 10min on icewith lysis buffer (25mMHEPES, 2.5 nMEDTA,
0.1% Triton X-100, 1 mM PMSF, and 5 g/ml leupeptin). After
protein content determination with Bradford reagent, total
protein was boiled in Laemmli sample buffer and submitted to
8–15% SDS-PAGE. Proteins were transferred to immunoblot
PVDFmembrane, and, after blockingwith 3%BSAor 5%nonfat
dry milk, membranes were incubated overnight with several
antibodies, as indicated. Immunoreactive bands were visual-
ized using the ECL Western blotting protocol. Densitometric
analysis of the bandswas performed using ImageJ software. The
anti-phospho-PERK (Thr-980) (catalog no. 3179), anti-phos-
pho-eIF2 (Ser-51) (catalog no. 9721), anti-phospho-JNK (cat-
alog no. 9251), anti-phospho-STAT3 (catalog no. 9131), anti-
phospho-MAPK (catalog no. 9101), and anti-MAPK (catalog
no. 4695) antibodies were from Cell Signaling Technology
(Danvers, MA). The anti-JNK (sc-571), anti-IR  (sc-711), anti-
PERK (sc-13073), anti-eIF2 (sc-11386), anti-GRP78 (sc-
376768), anti-CHOP (sc-7351), anti-phospho-p38 (sc-17852),
anti-p38 (sc-9212), anti-IRS1 (sc-559), anti-IRS2 (sc-8299),
anti-phospho-IR (sc-25103), anti-phospho-Akt (Thr-308)
(sc-16646), anti-phospho-Akt (Ser-473) (sc-7985), anti-Akt
(sc-8312), anti-PTP1B (sc-1718), and anti-PTEN (sc-7974)
antibodies were from Santa Cruz Biotechnology, Inc. Anti--
tubulin (T5168) and anti--actin antibodies (A5441) were from
Sigma-Aldrich. Anti-arginase 1 antibody (610708) was pur-
chased from BD Biosciences.
RNA Isolation and Quantitative PCR—Total RNA was iso-
lated using TRIzol reagent and was reverse transcribed using a
SuperScriptTM III First-Strand Synthesis System for quantita-
tive PCR following the manufacturer’s indications. Quantita-
tive PCR was performed with an ABI 7900 sequence detector
FIGURE 1. Proinflammatory components of the conditionedmedium from RAW 264.7 macrophages stimulated with palmitate are mediators of the
impairment in insulin signaling in hepatocytes. Hepatocytes were treated 24 h with conditioned media collected from RAW 264.7 cells treated with BSA
(CM-B) or palmitate (CM-P) for 24 h (A) or with conditionedmedia collected from RAW 264.7 cells treated with BSA (CM-B) or palmitate (CM-P) for 8 h and then
reefed with freshmedium for a further 16 h (B). Then cells were stimulated with 10 nM insulin for 10min. Total protein was analyzed byWestern blot using the
indicated antibodies. Representative blots are shown (n 3 experiments performed in duplicate).
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using the SYBR Green method and d(N)6 random hexamer
with primers purchased from Invitrogen. PCR thermocycling
parameters were 95 °C for 10 min, 40 cycles of 95 °C for 15 s,
and 60 °C for 1 min. Each sample was run in triplicate and
normalized to 18 S RNA. -Fold changes were determined using
the Ct method. Primer sequences are available upon
request.
Quantification of Apoptosis—Cells were grown in glass cov-
erslips and treated as described above. Then cells were washed
twice with PBS and fixed in p-formaldehyde (4%) for 10 min,
and characteristic morphological changes of apoptosis were
assessed by staining nuclei with DAPI followed by the analysis
by fluorescence microscopy.
Statistical Analysis—Data are presented as mean S.E. and
were compared by using the Bonferroni analysis of variance
test. All statistical analyses were performed using IBM SPSS
Statistics 21.0 (SPSS Inc., IBM, Armonk, NY) software with
two-sided tests. Differences were considered statistically signif-
icant at p 0.05.
RESULTS
Conditioned Medium from Macrophages Stimulated with
Palmitate (CM-P) Impairs Insulin Signaling in Mouse He-
patocytes—The liver is composed primarily of hepatocytes but
also contains blood and lymph vessels, nerves, and immune
cells. Because all of these cell types can potentially respond to a
high fat-mediated inflammatory environment in vivo, we used a
cell culture-based approach to investigate the specific cross-
talk between macrophages and hepatocytes in the context of
fatty acid overload. For this goal, RAW 264.7 macrophages
were treated with palmitate, a typical saturated FFA found in
Western diets, for 24 h. Then, culture medium (conditioned
FIGURE2. Insulin signaling isdifferentiallymodulated inhepatocytespretreatedwithconditionedmediumfromRAW264.7macrophagesstimulated
with oleate or palmitate. A, conditioned medium from RAW 264.7 macrophages treated with BSA (CM-B), oleate (CM-O), or palmitate (CM-P) was added to
immortalized mouse hepatocytes for 24 h. Then cells were stimulated with 10 nM insulin for 10 min. Total protein was analyzed by Western blot using the
indicated antibodies. Representative blots are shown. After quantification of all blots, results are expressed as the percentage of insulin stimulation or
percentage of protein expression relative to the CM-B condition (100%) and are mean  S.E. (error bars) (n  6 independent experiments performed in
duplicate). *, p  0.05; **, p  0.01; ***, p  0.001, CM-O or CM-P, respectively, versus CM-B. B, human primary hepatocytes were treated with conditioned
medium fromRAW264.7macrophages treatedwith BSA, oleate, or palmitate as described inA. Total proteinwas analyzedbyWestern blot using the indicated
antibodies. Representative blots are shown (n 4 experiments performed in duplicate).
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medium) was removed. Conditioned medium was hereafter
called CM-P (collected from RAW 264.7 cells treated with
palmitate) or CM-B (from RAW 264.7 cells treated only with
BSA as a control). CM-B or CM-P was added to immortalized
mouse hepatocytes generated and validated in our laboratory
(33) for a further 24 h, and then cellswere stimulatedwith 10nM
insulin for 10min. As depicted in Fig. 1A, IR tyrosine phosphor-
ylation was reduced in hepatocytes preincubated with CM
from palmitate-treated macrophages compared with those
treated with control CM-B. Likewise, levels of IRS1 decreased
only in hepatocytes treated with CM-P in parallel with
decreases in Akt Ser-473 and Thr-308 phosphorylation in
response to insulin. Notably, we found similar impairment of
the insulin signaling in hepatocytes treated with CM collected
from RAW 264.7 cells stimulated with palmitate for 8 h and
then refed with freshmedium for a further 16 h (Fig. 1B). These
results indicate that the components of the CM-P are sufficient
to mediate the negative effects observed in insulin signaling in
hepatocytes.
Insulin Signaling Is Oppositely Modulated in Mouse and
Human Hepatocytes Pretreated with Conditioned Medium
fromMacrophages Stimulated with Palmitate or Oleate—Next,
we checked that the effects of CM-P on insulin signaling in
hepatocyteswere specific to palmitate treatment and not due to
the FFA overload. For this goal, we obtained conditioned
medium from RAW 264.7 cells treated with oleate, a well
known nontoxic monounsaturated FFA. Conditioned medium
was hereafter called CM-O (collected from RAW 264.7 cells
treated with oleate). After the addition of CM-B, CM-O, or
CM-P for 24 h, immortalized mouse hepatocytes were stimu-
lated with 10 nM insulin for 10 min. As depicted in Fig. 2A,
insulin-induced IR tyrosine phosphorylation was enhanced in
hepatocytes preincubated with CM-O as compared with con-
trol hepatocytes preincubated with control CM-B. As stated
above (Fig. 1A), IR tyrosine and Akt phosphorylation was
reduced in the presence of CM-P (Fig. 2A). Moreover, protein
levels of IR and IRS1 decreased only in hepatocytes treatedwith
CM-P. In agreement with enhanced IR tyrosine phosphoryla-
FIGURE 3.Palmitate, but not oleate, treatment induces proinflammatory cytokine and chemokine gene expression in RAW264.7macrophages. RAW
264.7macrophageswere treatedwith BSA (B), oleate (O), or palmitate (P) for 24 h. A, TNF, IL-6, IL-1, MCP1, IL-10, arginase 1, Mcr1, andMgl1mRNA levels
were analyzed by quantitative RT-PCR. Results are expressed as -fold increase relative to the BSA condition and aremean S.E. (error bars) (n 4). *, p
0.05; **, p 0.01; ***, p 0.001, O or P, respectively, versus B. B, total protein was analyzed by Western blot using the indicated antibodies. Represen-
tative blots are shown (n  4 experiments performed in duplicate). C, RAW 264.7 macrophages were transfected with arginase 1 or scrambled siRNA
oligonucleotides, and after 36 h, oleate was added for a further 24 h. Left, protein levels of arginase 1 were analyzed by Western blot. Results are
expressed as the percentage of decrease relative to the scrambled condition (100%) and are mean S.E. (n 3 independent experiments performed
in duplicate). *, p 0.05; **, p 0.01 arginase 1 siRNA versus scrambled. Right, CM of RAW 264.7 cells transfected with scrambled or arginase 1 siRNA (25
nM) and treated for 24 h with oleate (CM-Oscr or CM-OsiArg1, respectively) was added tomouse hepatocytes. After 24 h, hepatocytes were stimulated with
10 nM insulin for 10min. Total protein was analyzed byWestern blot using the indicated antibodies. Representative blots are shown (n 3 independent
experiments performed in duplicate).
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tion and the maintenance of intact levels of IR and IRS1, the
response to insulin inAkt phosphorylation at both residues was
increased in hepatocytes treated with CM-O compared with
those treatedwithCM-B.Notably, IRS2 levels were not affected
by treatment of hepatocytes with either CM. Then the differ-
ential effect of both types ofCMwas assessed in humanprimary
hepatocytes. Fig. 2B shows that the decreased IR/IRS1/Akt-me-
diated insulin signaling was also observed in human primary
hepatocytes pretreated with CM-P, whereas a significant
enhancement of this signaling pathway was found in human
hepatocytes pretreated with CM-O. Altogether, these results
indicate opposite effects of palmitate and oleate in triggering
cross-talks between macrophages and hepatocytes with rele-
vant effects in insulin signaling.
Differential Effects on the Content of Proinflammatory
Cytokines and Eicosanoids Secreted by Macrophages Stimu-
lated with Palmitate or Oleate—In an attempt to characterize
the molecules released bymacrophages to the CM, we assessed
the expression of proinflammatory cytokines characteristic of
M1 macrophage polarization by real-time PCR. Treatment of
RAW 264.7 macrophages with palmitate, but not oleate,
increased IL6, IL1, TNF, and MCP1 mRNA levels (Fig. 3A).
Moreover, the induction of inducible nitric-oxide synthase, a
key proinflammatory marker, was only detected in RAW 264.7
cells treated with palmitate (Fig. 3B). On the other hand, oleate
treatment significantly up-regulatedmRNA levels of arginase 1,
a relevant M2 anti-inflammatory enzyme. Notably, no signifi-
cant differences were observed in other M2 polarization mark-
ers, such as IL10, Mcr1, and Mgl1. The elevated levels of argi-
nase 1 found in RAW 264.7 macrophages treated with oleate
prompted us to further investigate its role in the cross-talk
between macrophages and hepatocytes. For this goal, RAW
264.7 cells were transfected with control (scrambled) or argi-
nase 1 siRNA. After 36 h, cells were treated with oleate for a
further 24 h. CM-O of scrambled or arginase 1
siRNA-transfected cells (CM-Oscr or CM-OsiArg1, respectively)
was added to mouse hepatocytes, and after 24 h, insulin signal-
ing was analyzed. As shown in Fig. 3C (left), arginase 1 protein
levels were decreased in siRNA-transfected RAW 264.7 cells
compared with the scrambled condition. Importantly, insulin
signaling, monitored by Akt Thr-308 phosphorylation, was
markedly decreased in hepatocytes pretreatedwithCM-OsiArg1
comparedwith those pretreatedwith CM-Oscr, althoughwith a
minor effect at the Ser-473 residue (Fig. 3C, right).
Next, we performed a broad lipidomic screening of the CM
collected from RAW 264.7 cells treated with BSA, oleate, or
palmitate (Fig. 4). The total amount of eicosanoids detected in
the CM-P was higher compared with CM-O or control CM-B,
including cyclooxygenase-derived products, such as PGE2,
PGD2, PGF2, tromboxane B2, 12-HHT, and 11-HETE, as well
as PGD2 dehydration metabolites like 15d-PGD2, 15d-PGJ2,
and 15k-PGE2. Moreover, a greater increase of lipoxygenase-
derivedmolecular species, such as 15-HETE, prostaglandin D2,
and leucoxene B4, was observed in CM-P as compared with
CM-O. Surprisingly, levels of LTB4 were lower in CM-O com-
pared with those found in CM-P or CM-B.
Conditioned Medium from RAW 264.7 Macrophages Stimu-
lated with Palmitate, but Not Oleate, Activates Stress Kinases
and ER Stress Signaling and Induces Lipoapoptosis in He-
patocytes—It is well known that cytokines secreted by macro-
phages, such as TNF and IL6, induce insulin resistance in
hepatic cells through the activation of proinflammatory signal-
ing pathways (37, 38). Moreover, FFAs and their metabolites
have been involved in the activation of stress-mediated signal-
ing pathways linked to chronic metabolic low grade inflamma-
tion (39). On that basis, we tested whether oleate and/or palmi-
tate activate stress kinases in hepatocytes through their effects
in macrophages. As depicted in Fig. 5A, the phosphorylation of
FIGURE 4.Differential effect of palmitate and oleate in total eicosanoid content in RAW 264.7macrophages. Analysis of eicosanoids from the CM from
RAW264.7macrophages treatedwith BSA (B), oleate (O), or palmitate (P) by high performance liquid chromatography/tandemmass spectrometry. Results are
expressed as pmol/mg of protein. Data are shown asmeans of three independent experiments with triplicate determinations. In all cases, S.E. was below 10%;
therefore, error bars were omitted for the sake of clarity.
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inflammation-linked stress kinases (STAT3, JNK, p38 MAPK,
and ERK) and kinases related to ER stress (PERK and eIF2)
was rapidly detected (at 30min) in hepatocytes stimulated with
CM-P but not with CM-O; the latter remained at similar basal
levels of hepatic cells stimulated with CM-B. This pattern of
kinase activation concurred with an increase in the expression
of GRP78 and CHOP, two relevant ER stress markers, and with
the detection of the active fragment of caspase-3 after 24 h of
CM-P challenge (Fig. 5B). Conversely, neither increasedGRP78
and CHOP expression nor active caspase-3 fragment were
detected in hepatocytes treated with CM-O or CM-B. Notably,
in hepatocytes treated with CM-P, the activation of caspase-3
correlated with increased apoptosis (Fig. 5C).
Conditioned Medium from Kupffer Cells Stimulated
with Palmitate Activates Stress-mediated Signaling Path-
ways and Induces Insulin Resistance in Primary Mouse
Hepatocytes—In order to confirm the differential effects of oleate
and palmitate in a physiological context, we isolated and cultured
Kupffer cells fromC57/BL6mice and these residentmacrophages
were stimulated with oleate or palmitate for 24 h. The purity of
Kupper cells was checked by the analysis of CD68 and F4/80
mRNA levels (Fig. 6A). In agreement with the results found in
RAW 264.7 cells, an increase of IL6, IL1, TNF, and MCP1
mRNA levels was observed only in palmitate-stimulated Kupffer
cells (Fig. 6B). By contrast, oleate increased mRNA levels of M2
polarizationmarkers (IL10,Mcr1,Mgl1, and arginase 1).We con-
firmed these data analyzing the activation of stress kinases in pri-
mary mouse hepatocytes treated with CM from Kupffer macro-
phages stimulated with oleate or palmitate (CMK-O or CMK-P,
respectively). As a control, hepatocytes were stimulated with CM
fromKupffer cells loadedwithBSA(CMK-B).As shown inFig. 6C,
phosphorylations of STAT3, p38 MAPK, JNK, PERK, and eIF2
were observed exclusively in hepatocytes treated with CMK-P. In
light of these data, CHOP and the active fragment of caspase-3,
indicators of apoptosis, were detected only in hepatocytes treated
with CMK-P (Fig. 6D).
FIGURE5.ConditionedmediumfromRAW264.7macrophages treatedwithpalmitateactivatesstresskinasesandERstressand induces lipoapoptosis
in hepatocytes. Conditionedmedium from RAW 264.7macrophages treated with BSA (CM-B), oleate (CM-O), or palmitate (CM-P) was added to immortalized
mouse hepatocytes for several time periods (30min (A), 24 h (B), and 24 and 48 h (C)). A and B, total protein was analyzed byWestern blot using the indicated
antibodies. Representative blots are shown (n  4 independent experiments performed in duplicate). C, representative images after DAPI staining. After
quantification of apoptotic nuclei from all images, results are expressed as the percentage of the number of apoptotic nuclei and are mean S.E. (error bars)
(n 3 independent experiments performed in duplicate). *, p 0.05; ***, p 0.001, CM-P versus CM-B.
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Next, we analyzed the effects of Kupffer cell-derived prod-
ucts on insulin signaling in hepatocytes. For this goal, primary
hepatocytes were treated with CMK-P or CMK-O for 24 h and
subsequently stimulated with 10 nM insulin for 10 min. As
depicted in Fig. 6E, insulin-induced tyrosine phosphorylation
of the IR andAkt phosphorylation at both Ser-473 and Thr-308
residues was enhanced in hepatocytes pretreatedwith CMK-O,
whereas these responsesweredecreased inhepatocytespretreated
with CMK-P. These results also reflect an opposite paracrine
cross-talk between hepatocytes and resident macrophages.
Lower Levels of PTP1B and LTB4 Contribute to the Insulin
Sensitization Induced by CM-O in Hepatocytes—We evalu-
ated the possibility that changes in the expression of negative
modulators of the early steps of the insulin signaling could
account for the insulin sensitization induced by CM-O or
CMK-O in hepatocytes. Among them, PTP1B was a poten-
tial candidate, given its ability to directly dephosphorylate
tyrosine residues of the IR (40). In addition, PTEN, a lipid
phosphatase, limits Akt activation by decreasing levels of
phosphatidylinositol 3,4,5-triphosphate (41). Consistent
with this hypothesis, we measured the expression of both
phosphatases in hepatocytes incubated with CM from RAW
264.7 cells treated with BSA or oleate. As depicted in Fig. 7,A
and B, PTP1B and PTEN protein content was decreased in
hepatocytes treated with CM-O without changes at their
mRNA levels.
FIGURE6.ParacrineeffectsofprimaryKupffercellsstimulatedwithpalmitateoroleate instressandinsulin-mediatedsignalingpathways inprimarymouse
hepatocytes. A, Kupper cells and hepatocytes were isolated frommice as described under “Experimental Procedures,” and mRNA levels of CD68 and F4/80 were
determined. CD68 and F4/80were undetectable in hepatocytes (n 3 independent experiments performed in duplicate). B, primary Kupffer cells were treatedwith
BSA (B), oleate (O), or palmitate (P) for 24 h. TNF, IL-6, IL-1, MCP1, IL-10, arginase 1,Mcr1, andMgl1mRNA levels were analyzed by quantitative RT-PCR. Results are
expressed as -fold increase relative to BSA condition (taken as 1) and aremean S.E. (error bars) (n 3). *,p 0.05; **,p 0.01,Oor P, respectively, versus B.C andD,
conditionedmedium fromprimary Kupffer cells treatedwithBSA (CMK-B), oleate (CMK-O), or palmitate (CMK-P)was added toprimarymousehepatocytes for several
timeperiods (30min (C) and24h (D)). Total proteinwasanalyzedbyWesternblotusing the indicatedantibodies. Representativeblots are shown (n3 independent
experiments).E, CMKwasadded toprimaryhepatocytes for 24h. Thencellswere stimulatedwith10nM insulin for 10min. Total proteinwasanalyzedbyWesternblot
using the indicated antibodies. Representative blots are shown (n 3 independent experiments).
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Because we detected lower levels of LTB4 in CM-O com-
pared with those found in CM-P or control CM-B, we analyzed
the involvement of this lipid species in the effects of oleate in
insulin sensitization in hepatocytes. LTB4 is a proinflammatory
lipid mediator generated from arachidonic acid through the
activities of 5,5-lipoxygenase, 5-lipoxygenase-activating pro-
tein, and leukotriene A4 hydrolase (42, 43). First, we checked
whether LTB4 directly modulates insulin sensitivity in hepato-
cytes. As depicted in Fig. 8A, LTB4 decreased insulin-induced
IR tyrosine phosphorylation and Akt phosphorylation (Ser-473
and Thr-308) in a dose-dependent manner. These results indi-
cate that LTB4 per se induces insulin resistance in hepatocytes.
Next, we evaluated whether LTB4 was able to modulate PTP1B
and PTEN expression in hepatic cells and found higher levels of
both phosphatases in LTB4-treated hepatocytes comparedwith
the controls (Fig. 8B). Based on previous studies that reported
on one hand increased NFB activity in HepG2 hepatoma cells
upon treatment with LTB4 (44) and, on the other, NFB-medi-
ated increase in PTP1B gene expression during chronic inflam-
mation in obesity (45), we analyzed IKK-IB in hepatocytes
treatedwith LTB4.As shown in Fig. 8C, LTB4 increased IKK/
and IB phosphorylation at early time periods, leading to
IB degradation at 24 h. Notably, stress kinases that regulate
insulin signaling, such as STAT3, JNK, and p38 MAPK, were
also rapidly phosphorylated in response to LTB4. As a step fur-
ther, we investigated whether LTB4 effects on PTP1B and
PTEN in hepatocytes were mediated by the BLT1 receptor. For
this goal, immortalized mouse hepatocytes were transfected
with BLT1 or scrambled siRNA oligonucleotides. After 36 h,
LTB4 was added for a further 24 h, and PTP1B and PTEN levels
were analyzed. Fig. 8D shows the efficacy of BLT1 silencing in
immortalized hepatocytes that was able to down-regulate
LTB4-induced PTP1B and PTEN, although the latter did not
reach statistical significance. Finally, hepatocytes were treated
with CM-O supplemented with LTB4 and then stimulated with
insulin. As shown in Fig. 9A, both IR and Akt phosphorylations
were decreased in hepatocytes incubatedwithCM-Oplus LTB4
compared with hepatocytes treated with CM-O alone. More-
over, after CM-Ochallenge in the presence of LTB4, the expres-
sion of PTP1B and PTEN was increased and reached levels
comparable with the CM-B condition (Fig. 9B). Again, this
effect was particularly significant in the modulation of PTP1B
levels.
DISCUSSION
In obesity-associated insulin resistance, M1-like macro-
phage polarization state has been associated with the enhance-
ment of the proinflammatory milieu by the ability to secrete
proinflammatory cytokines. The surrounding insulin-resistant
adipocytes trigger proinflammatory signaling pathways in
macrophages through their binding to Toll-like receptors (46–
48). However, we know now that beyond the interplay between
adipocytes and adipose tissue-resident macrophages, these
inflammatory signals also dysregulate key metabolic responses
in peripheral tissues, thereby exacerbating insulin resistance
(3).
The liver is a target organ of the inflammatory mediators. In
obesity, the hepatic lipid accumulation (first hit) together with
the proinflammatory input (second hit) trigger the necroin-
flammatory changes that are recognized histopathologically as
steatohepatitis (49). Of relevance, adipose tissue inflammation
has been correlated with hepatic steatosis in humans (50). In
this study, we have dissected for the first time the molecular
cross-talk between signals emerging frommacrophage-derived
products in response to fatty acid overload and insulin signaling
in hepatocytes. As a step further, we attempted to compare the
responses of hepatocytes to macrophage-secreted cytokines
and bioactive lipids derived from oleate or palmitate together
FIGURE7.Lower levelsofPTP1BandPTENcontribute to the insulin sensitization inducedbyCM-O inhepatocytes.ConditionedmediumfromRAW264.7
macrophages treatedwith BSA (CM-B) or oleate (CM-O)was added to immortalizedmousehepatocytes for 24h.A, PTP1B andPTENmRNA levelswere analyzed
by quantitative RT-PCR. Results are expressed as -fold increase relative to CM-B condition (taken as 1) and are mean  S.E. (error bars) (n  3 independent
experiments performed in duplicate). B, total protein was analyzed by Western blot using the indicated antibodies. Representative blots are shown. After
quantification of all blots, results are expressed as the percentage of protein expression relative to CM-B condition (100%) and are mean  S.E. (n  3
independent experiments performed in duplicate). *, p 0.5; ***, p 0.001 CM-O versus CM-B.
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with FFAs mimicking the circulating proinflammatory milieu.
Interestingly, an opposite response in insulin-mediated IR tyro-
sine phosphorylation, the earliest event in the insulin signaling
cascade, was found in both mouse and human hepatocytes
exposed to the CM from macrophages treated with oleate or
palmitate, with a significant increase or decrease, respectively,
as compared with control hepatocytes (treated with CM-BSA).
This opposite response was also evidenced in Akt phosphory-
lation (at both Ser-473 and Thr-308), a critical node of insulin’s
metabolic actions in hepatic cells (51). Thus, these results sug-
gested that oleate and palmitate induce different secretory
responses in macrophages, and this might differentially modu-
late insulin signaling in liver cells. In light of these findings, the
M1 polarization state induced by palmitate, reflected by ele-
vated TNF, IL6, IL1, and inducible nitric-oxide synthase, in
agreement with Samokhvalov et al. (30), was not observed in
RAW 264.7 macrophages loaded with oleate. The absence of
M1 polarization is critical to understand the modulation of
insulin signaling by oleate in hepatocytes, as will be discussed
below. In fact, increased arginase 1 levels reflect an M2 profile
of RAW 264.7 macrophages after oleate challenge, in agree-
ment with recent results reported by Camell and Smith (52) on
the role of dietary oleic acid in M2 macrophage polarization.
Indeed, when arginase 1 expression was reduced in macro-
phages by transfection with siRNA, the CM produced in
response to oleate (CM-OsiArg1) partly reverted the enhanced
FIGURE 8. LTB4 inhibited insulin signaling and induced PTP1B andPTEN via BLT1 in hepatocytes. A, immortalized hepatocytes were treatedwith various
doses of LTB4 for 24 h followed by stimulation with 10 nM insulin for 10 min. Total protein was analyzed by Western blot using the indicated antibodies.
Representative blots are shown (n 3 independent experiments performed in duplicate). B, immortalized hepatocyteswere treatedwith 0.5M LTB4 for 24 h,
and the expression of PTP1B and PTEN was analyzed by Western blot. After quantification of all blots, results are expressed as the percentage of protein
expression relative to control condition (100%) and are themean S.E. (error bars) (n 3 independent experiments performed in duplicate). *, p 0.05 LTB4
versus control. C, hepatocytes were treated with 0.5 M LTB4 for the indicated time periods, and the phosphorylation of the kinases indicated was analyzed.
IB levelswere analyzed at 24 h. Representative blots of three independent experiments are shown.D, hepatocyteswere transfectedwith BLT1 or scrambled
siRNA oligonucleotides, and after 36 h, cells were treated with 0.5 M LTB4 for 24 h. Left, mRNA levels of BLT1 were analyzed by RT-PCR. Results are expressed
as -fold decrease relative to the scrambled condition and are mean S.E. (n 3 independent experiments performed in duplicate). *, p 0.05 BLT1 siRNA
versus scrambled. Right, PTP1B and PTENprotein levels were analyzed byWestern blot. After quantification of all blots, results are expressed as the percentage
ofprotein expression relative to the scrambled condition (100%) andaremeanS.E. (n3 independent experimentsperformed induplicate). *,p0.05BLT1
siRNA versus scrambled.
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insulin signaling in hepatocytes. These results indicate that
although arginase 1 is involved, a complete M2 polarization
may be needed tomediate the effects of CM-O on the enhance-
ment of insulin signaling in hepatocytes, and this approach
could offer a therapeutic benefit against insulin resistance in
the liver.
The ER plays a central role in the determination of cell fate
under conditions of stress. Increased ER stress has been shown
to contribute to the development of non-alcoholic fatty liver
disease (17). In this regard, CM-P-treated hepatocytes rapidly
activated the PERK branch of UPR by inducing PERK, eIF2,
and JNKphosphorylation, resulting in increasedCHOPexpres-
sion. Under these experimental conditions, STAT3 phosphor-
ylation was also increased; this response is probably mediated
by the proinflammatory cytokines IL6 and IL1. Moreover,
TNF-mediating signaling might also boost JNK and p38
MAPK activation. The convergence of all of these proinflam-
matory signaling cascades leads to a negative cross-talk with
insulin signaling, resulting in the degradation of both IR and
IRS1 (Fig. 10A), which agrees with results reported in hepato-
cytes treated with palmitate (53, 54). Notably, IRS2 levels were
not affected by either CM-P or CM-O in human and mouse
hepatocytes, indicating that IRS2 might be more resistant to
post-translational degradation compared with IRS1, as re-
ported in primary mouse hepatocytes (55). Therefore, lower IR
and IRS1 levels detected in hepatocytes stimulated with CM-P
evidence the contribution of the early activation of stress
kinases in the reduced insulin-mediated Akt phosphorylation.
Neither the early activation of stress kinases nor CHOP expres-
sionwas detected in hepatocytes treatedwithCM-O, highlight-
ing the absence of oleate-mediated proinflammatory responses
in the macrophage-hepatocyte axis.
Activation of Kupffer cells, the hepatic resident macro-
phages, to secrete proinflammatory mediators is a key event in
the initiation of non-alcoholic fatty liver disease, and limiting
their polarization into an M1 phenotype is considered an
FIGURE 9. LTB4 impairs the enhancement of insulin signaling induced by CM-O in hepatocytes. A, conditioned medium from RAW 264.7 macrophages
treatedwithBSA (CM-B) or oleate (CM-O)was added to immortalizedmousehepatocytes for 24h in thepresenceor absenceof LTB4 (0.5M) followedby insulin
stimulation (10 nM for 10min). Total proteinwas analyzed byWestern blot using the indicated antibodies. Representative blots are shown (n 4 independent
experiments performed in duplicate). B, conditioned medium from RAW 264.7 macrophages treated with BSA (CM-B) or oleate (CM-O) was added to immor-
talized mouse hepatocytes for 24 h in the presence or absence of LTB4 (0.5 M). Total protein was analyzed by Western blot using the indicated antibodies.
Representativeblots are shown.After quantificationof all blots, results are expressedas thepercentageofproteinexpression relative toCM-Bcondition (100%)
and aremean S.E. (error bars) (n 3 independent experiments performed in duplicate). *, p 0.05; **, p 0.01; ***, p 0.001, CM-O versusCM-B. #, p 0.05;
###, p 0.001, CM-O plus LTB4 versus CM-O.
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attractive strategy against chronic liver inflammation (56–59).
It has been shown that depletion of Kupffer cells using gadolin-
ium chloride attenuated the development of steatosis and insu-
lin resistance in the liver, suggesting an important early role for
Kupffer cells in diet-induced alterations in hepatic insulin
resistance (57). The differential effect of palmitate and oleate in
proinflammatory cytokine secretion in RAW 264.7 macro-
phages was also found in primary Kupffer cells, and, impor-
tantly, similar differences were observed in the activation of
stress kinases and in the modulation of insulin signaling in pri-
mary hepatocytes after CM-P challenge. Of particular rele-
vance is the enhancement of insulin signaling in primary hepa-
tocytes incubated with CM from Kupffer cells loaded with
oleate, which reinforces the beneficial effects on insulin sensi-
tivity in a paracrine manner.
In addition to inflammation, FFA-induced lipotoxicity con-
tributes to the pathogenesis of non-alcoholic fatty liver disease
since saturated FFAs are the more toxic lipid species (60–62).
Although the evaluation of the apoptotic responses under
inflammatory conditions was not the major goal of this study,
we detected cleavage of caspase-3 together with an increase in
the percentage of apoptotic cells in hepatocytes treated with
CM-P, suggesting that the signals derived from themacrophage
M1 polarization are probably involved in lipoapoptosis. This
interesting issue deserves future research.
The fact thatCM-Opretreatment enhanced insulin signaling
in hepatocytes, reaching levels of IR and Akt phosphorylation
above the controls (treated with CM-B), together with the
observation that the levels of proinflammatory cytokines in
CM-O did not decrease below those found in the controls
prompted us to investigate additional macrophage-secreted
molecules that could account for insulin sensitization. In a
broad lipidomic analysis of eicosanoid species, we noted that
levels of LTB4 decreased in CM-O as compared with CM-B or
CM-P. LTB4 is involved in sustaining chronic inflammation
and insulin resistance in obesity (63, 64), and more recently,
deficiency of LTB4 receptor in mice (BLT1-deficient mice) has
been reported to confer protection against systemic insulin
resistance and diet-induced obesity (25). Notably, the livers of
BLT1-deficient mice showed decreased hepatic triglyceride
accumulation and enhanced Akt phosphorylation upon insulin
injection. Preincubation of mouse hepatocytes with LTB4
decreased insulin-induced signaling at the level of the IR tyro-
sine phosphorylation and subsequently decreased Akt phos-
phorylation. Notably, in mouse hepatocytes, LTB4 was able to
up-regulate both PTP1B and PTEN, two phosphatases that
negatively modulate IR and Akt, respectively (40, 41), and this
effect was elicited via BLT1 because it was reverted by reducing
BLT1 levels with an specific siRNA. This is the first evidence
linking PTP1B and PTEN with the signaling pathways modu-
lated by a bioactive lipid. Regarding potential signaling path-
ways that mediate such an effect and in agreement with previ-
ous data in HepG2 hepatoma cells (44), the NFB pathway was
activated by LTB4 in mouse hepatocytes. Because it has been
demonstrated that NFB directly activates the transcription of
the ptpn1 gene during inflammation linked to obesity (45), our
data pinpoint the NFB-PTP1B axis as a potential mechanism
by which LTB4 negatively modulates IR tyrosine phosphoryla-
FIGURE 10.A, schematic representation of palmitate-inducedM1polarization ofmacrophages that leads to a negative cross-talkwith hepatic insulin signaling
through decreasing IR and IRS1. B, schematic representation of the beneficial effects of oleate in switching macrophage polarization by inducing M2 state to
enhance insulin sensitivity in hepatocytes. The involvement of PTP1B and PTEN in the effect of LTB4 via its receptor BLT1 is indicated.
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tion in hepatocytes. Based on these findings, when LTB4 was
added to CM-O insulin, sensitization was abolished in hepato-
cytes, as manifested by decreased IR tyrosine and Akt Ser-473
and Thr-308 phosphorylations. Importantly, the supplementa-
tion of CM-O with LTB4 up-regulated PTP1B protein levels in
hepatocytes. Previous findings have shown that macrophage-
derived factors in response to LPS enhance the effect of insulin
in muscle cells by increasing Akt phosphorylation, GLUT4
translocation to the plasmamembrane, and glucose uptake due
to an elevation of IL10 (30). Because no differences in IL10
levels were found between macrophages loaded with oleate or
BSA, our data pinpoint first LTB4 as one of the macrophage-
secreted lipid species that is decreased by oleate, leading to a
positive effect in the macrophage-hepatocyte axis and, second,
PTP1B as a critical node of the insulin signaling that is modu-
lated by levels of LTB4 via NFB. Although PTP1B has been
involved in obesity and inflammation (45, 65, 66), this is the first
study showing the modulation of PTP1B protein levels by a
macrophage-derived lipid product from oleate because
reduced levels of LTB4 in CM-O paralleled with decreased
PTP1B and enhancement of insulin-mediated IR tyrosine phos-
phorylation in hepatocytes. These data might be of relevance
because PTP1B has emerged as a therapeutic target against
obesity-mediated insulin resistance by its ability to regulate
peripheral (muscle and liver) insulin sensitivity (65, 67–72) as
well as the central control of appetite and energy expenditure
(45, 73, 74). Besides PTP1B, CM-O decreased PTEN content,
which boosts the enhancement of insulin signaling at the Akt
level, and this effect was also reverted by the addition of LTB4.
Althoughmuch less is knownof the regulation of PTENexpres-
sion by proinflammatory lipid mediators, our results are in line
with the work of Song et al. (75) demonstrating that the throm-
boxane A2 receptor up-regulates PTEN to attenuate insulin
signaling in endothelial cells. Moreover, recent data have
revealed that unsaturated FFAs up-regulate microRNA-21 to
induce PTEN degradation (76), strongly suggesting that the
contribution of this phosphatase to the modulation of insulin
signaling in hepatocytes under pro- or anti-inflammatory con-
ditions should also be considered.
In summary, we have demonstrated an endocrine/paracrine
cross-talk from macrophages/Kupffer cells to hepatocytes,
which bears opposite differences, depending on the polariza-
tion state of macrophages and the factors secreted by these
immune cells, as it has been manifested upon treatment with
palmitate or oleate. Furthermore, LTB4 was identified as a lipid
product thatmediates this cross-talk because reduced secretion
of LTB4 in oleate-stimulated macrophages concurs with the
enhancement of insulin sensitivity in hepatocytes, and this
effect is in part mediated by decreased PTP1B and PTEN levels.
To our knowledge and as summarized in Fig. 10B, this is the
first study providing data of the beneficial effects of oleate in
switching macrophages/Kupffer polarization to increase insu-
lin sensitization in hepatocytes.
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